InsidersTradesSigma
Pure Biologics S.A.: directors' dealings · Poland · KNF
KNF:pure-biologics-saPL·KNFMcap 26M€
Explore the full management transaction log of Pure Biologics S.A., a listed issuer based in Poland. Shares trade on PL PL, under the oversight of KNF. Market capitalisation: €26.1m. The latest transaction was reported on 18 May 2026 (Notification PDMR). Among the most active insiders: Anonymous (PDMR). All data is openly available.
8
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
2.13 €
Analyst consensus
Income statement
Gross profit−46 k€
Net income−19.4 M€0.0% margin
Valuation
Beta0.38
Balance sheet & cash
Market cap26.1 M€
Total debt14.1 M€
Free Cash Flow−10.8 M€
Profitability & ownership
ROA-116.3%
% insiders28.1%
% institutions0.5%
Last declaration on 18 May 2026
Declarations0 total
No declarations found
0 of 0 declarations